13th International Congress on Infectious Diseases Abstracts, Poster Presentations codon83 (Serine83Arginine) was noted in 1 strain having a CIP MIC of 0.012 and a NA MIC of 32 g/ml. All 28 strains that had a CIP MIC of 0.016-1.5 g/ml and frank resistance to NA (MIC ≥16 g/ml; DD zone of inhibition ≤13 mm) carried a transversion mutation in codon 83 of gyrA (Serine83Isoleucine). We noted another transversion mutation in codon 85 of parC (Serine85Leucine) in 14 of these 28 strains that had a CIP MIC of ≥0.125-1.5 and a NA MIC ≥256 g/ml). We could not detect any mutations in gyrB (n = 24) and parE (n = 28) genes.
codon83 (Serine83Arginine) was noted in 1 strain having a CIP MIC of 0.012 and a NA MIC of 32 g/ml. All 28 strains that had a CIP MIC of 0.016-1.5 g/ml and frank resistance to NA (MIC ≥16 g/ml; DD zone of inhibition ≤13 mm) carried a transversion mutation in codon 83 of gyrA (Serine83Isoleucine). We noted another transversion mutation in codon 85 of parC (Serine85Leucine) in 14 of these 28 strains that had a CIP MIC of ≥0.125-1.5 and a NA MIC ≥256 g/ml). We could not detect any mutations in gyrB (n = 24) and parE (n = 28) genes.
Conclusion: Reduced CIP-susceptibility and NA-resistance of V. cholerae is associated with a gyrA mutation (Serine83Isoleucine). A further decrease in CIP-susceptibility is associated with parC mutation (Serine85Leucine). Background:Organisms producing extended-spectrumˇ-lactamases(ESBL) are emerging around the world as a source of resistance to oxyiminocephalosporins such as cefotaxime, ceftazidime and ceftrioxone.This study was undertaken to study the prevalence of ESBL production by Klebsiella spp. in an urban hospital in South India.
Methods:Antimicrobial susceptibility testing of 213 strains of Klebsiella spp. isolated from various clinical specimens was carried out by disc diffusion method.One hundered and five strains found to be resistant to at least one of the third generation cepholosporins tested, viz, cefotoxime, ceftazidime and ceftrioxone were screened for the production of ESBL by phenotypic and genotypic methods.The phenotypic methods include the phenotypic confirmatory disc diffusion test (PCDDT)and double disc diffusion synergy test(DDST)and the genotypic method include the PCR amplification method.
Results:Of the 105 strains screened for ESBL producton 45(42.85%)and 43(40.95%) strains were positive by PCDDT and DDST methods respectively and 53(50.47%)strains were positive by genotypic method.
Conclusion:The prevalence of ESBL produced by Klebsiella spp. from various clinical conditions in this part of the country is 24.88% as detected by the genotypic method.The study suggests that ESBL production should be detected routinely to monitor the resistant organisms for implementation of appropriate infection control measures. Results: MICs for K. pneumoniae ML2011 showed that this strain was resistant to allˇ-lactams tested expect imipenem. K. pneumoniae ML20011 exhibited a high level of resistance to oxyimino cephalosporins. The strain was also resistant to kanamycin, chloramphenicol, ciprofloxacin, nalidixic acid, tetracycline and streptomycin. The disk diffusion method showed synergy between ceftazidime, cefotaxime, aztreonam, ceftriaxon, and amoxicillin-clavulanic acid against the strain and its transformants and transconjugants, suggesting plasmidmediated production of an ESBL enzyme. PCR analyses confirmed the presence of blaSHV in parent strain K. pneumoniae ML2011, and its transformants E. coli DH5˛/pML2011 and transconjugants E. coli HB101 X pML2011 indicating that this gene is located on transferable plasmid with estimated molecular size of 50 kb. Nucleotide sequence was performed on the coding region 861pb used to predict the amino acid sequence. This sequence was compared with strain K. pneumoniae Kp297 (DDBJ/EMBL/GeneBank accession no. EF035567) for nucleotide sequence homology and predicted amino sequence. Two amino acid substitutions were found at position 5 and 202, resulting respectively in a Met (ATG) to Leu (TTG) and an Arg (CGT) to Ser (AGT) changes. As theses substitutions not showed by other known SHVˇ-lactamases, the pI 7.3 from K. pneumoniae ML2011 appears to be a novel ESBL and has been designated SHV-104 (http://www.lahey.org). Background: Unlike reports of multidrug-resistant Salmonella enterica serovar typhi (S. typhi) in countries around the world, strains encountered in Jamaica have been uniformly susceptible to all the anti-typhoid drugs and also to other antibiotics by disc method. We have been maintaining these isolates on Dorset-egg medium over the years. In this report, we examine the MICs of 4 front-line antibiotics against 41 unduplicated isolates(one from a patient) encountered in consecutive 17 years between 1984 and 2000 at the University Hospital in Kingston, Jamaica.
Methods: The MICs were determined by E test(AB Biodisk, Solna, Sweden) using E. coli ATCC 25922 as control. Manufacturers' instructions in regard to media, inoculum density and incubation parameters were followed strictly. Our observation of extremely low MICs (see results below) made us to do the tests repeatedly and read the results independently by each of us (NCB and OH) and repeat again if we differed in reading by more than one E test dilution.
Results: The MICs(g/ml) of the four antibiotics were Chloramphenicol MIC range 2-4, MIC 50 3 and MIC 90 3; Ampicillin MIC range 0.125-1, MIC 50 0.25 and MIC 90 0.5; Trimethprim/Sulpha MIC range 0.023-0.064, MIC 50 0.032 and MIC 90 0.047; Ceftriaxone MIC range 0.023-0.047, MIC 50 0.032 and MIC 90 0.047. All isolates were susceptible. MICs were extremely low, fell in a narrow range and far below the standard susceptible(CLSI) Breakpoint MICs of the antibiotics. We have not seen any report of such a highly susceptible strains of typhoid bacilli from anywhere in the world.
Conclusion: Considering the growing increase of multidrug-resistant typhoid in countries around the world and reports of isolation of strains with MICs of front-line antibiotics of more than 256 g/ml(Hirose K et al Antimicrob Ag Chemother 45:956-958,2001), the highly susceptible nature of strains encountered in Jamaica is noteworthy. These unique strains which we call 'Jamaica strains' have been persisting in this island country throughout the years. Carbapenem-resistant Acinetobacter spp. have gained increasing significance as opportunistic pathogens in hospitalized patients. Carbapenem resistance is often associated with the loss and/or decrease in outer membrane protein and overexpression of multidrug efflux systems. In this study, we describe a study on carbapenem resistance mechanisms involved in Acinetobacter spp. isolated from UMMC.
Methods: 39 carbapenem-resistant clinical isolates of Acinetobacter spp. obtained from inpatients at the University Malaya Medical Centre were used in this study. Preliminary screening for carbapenemase production was carried out and IEF was determined in the strains. The isolates were analyzed for the presence of the blaIMP gene using PCR and confirmed by Southern hybridization to obtain the location of this gene. Other resistance mechanisms such the presence of AdeABC efflux pump genes were also determined by PCR followed by inactivation by plasmid insertion and the resultant mutants were tested for their antimicrobial susceptibilities. Presence of outer membrane proteins were determined by SDS-PAGE. Iron-regulated outer membrane proteins (IROMPs) were expressed under iron deficit conditions as these are possible targets of antimicrobial therapy. Thus, antibodies against these IROMPs were raised and bactericidal activity of the strains was determined.
Results: Out of the 39 strains only two strains, S26 and S90, both A. calcoaceticus were positive for the presence of metallo-ˇ-lactamases. Both these strains had similar MIC values for imipenem, cefotaxime, and aztreonam at 32, 512, and 64 g/ml respectively. IEF analysis showed that both strains had a band of pI 8.0 which corresponded to that of blaIMP-4, while an additional band of pI 7.0 was present in strain S90. Strains, S26 and S90, were PCR positive for blaIMP, while the remaining 37 harbored blaOXA-23. Amplification and subsequent nucleotide sequencing of the entire coding region of blaIMP confirmed the identity of the blaIMP amplicon to be blaIMP-4. Plasmid analysis revealed that only the two strains, S26 and S90, carried plasmids: 147, 63, 36 in both strains with an additional 7 kb plasmid in S26. Southern blot hybridization showed that the blaIMP-4 gene was located on the 36 kb plasmid in strain S26 and was confirmed to be located on Class 1 integron. Screening and nucleotide sequencing of the Class 1 integron revealed identical genes: blaIMP4, qacG, aacA4, and catB3 in the 2 strains. However, PFGE analyses showed that S26 and S90 had different genotypes. Screening of efflux pump genes showed that 36 strains harboured all the 3 genes (adeA, adeB, and adeC). Inactivation of these individual genes showed decreased antimicrobial susceptibility indicating its contribution towards the development of antimicrobial resistance. Besides that, all the strains showed loss of a 27 kDa OMP. The monoclonal antibodies produced showed bactericidal effect against the organism tested and it specifically killed
